SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-023268
Filing Date
2024-06-10
Accepted
2024-06-10 07:00:27
Documents
12
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 653029
2 formdef14a_001.jpg GRAPHIC 3109
3 formdef14a_002.jpg GRAPHIC 1317
4 formdef14a_003.jpg GRAPHIC 1609
5 formdef14a_009.jpg GRAPHIC 1102
6 formdef14a_004.jpg GRAPHIC 41346
7 formdef14a_005.jpg GRAPHIC 29154
8 formdef14a_007.jpg GRAPHIC 96607
9 formdef14a_008.jpg GRAPHIC 80120
10 formdef14a_006.jpg GRAPHIC 4482
11 proxycard_001.jpg GRAPHIC 189093
12 proxycard_002.jpg GRAPHIC 139878
  Complete submission text file 0001493152-24-023268.txt   1465205
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34951 | Film No.: 241031433
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)